Published in Physician Business Week, August 10th, 2004
Researchers in Northern Ireland conducted a study "to obtain information about the use and subjective benefits of inhaled therapies in patients with bronchiectasis and to determine if these benefits were related to the presence of airflow obstruction."
"One hundred and twenty patients completed a questionnaire on inhaled therapies and performed spirometry," explained B. O'Neill and coauthors at Belfast City Hospital.
"Inhalers were used daily by 85/120 patients with bronchiectasis and 42/120 patients had a nebulizer," published data...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week